In particular, the impact of NT5DC2 with respect to p53 mutations, isoforms and deficiency itself and their effect on tumor stroma and on CAFs should further be investigated to determine whether it adversely affects the outcome of NSCLC course. The gene discussed is TP53; the disease is non-small cell lung carcinoma.